A Global Recession Drives New Business Strategies and Evolving Business Models in the Biopharma IndustryDecision ResourcesSeptember 15, 2009 36 Pages - SKU: DECR2444564 |
|
Gilead Sciences, Inc. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
Gilead Sciences, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Gilead Sciences, Inc. - Product Pipeline Review - 2012” provides data on the Gilead Sciences, Inc.’s research and development focus. The report
|
more...
|
$500.00
|
|
541711 Research and Development In Biotechnology: State Industry Market Evaluator
6/1/2012 | published by: BizMiner
This State Industry Market Evaluator reports on industry trends broken out for each US state. Each state sub-report is comprised of eight pages of data. Statistics are displayed for 2008-2009-2010 and 2011q2 for these measures:
|
more...
|
$699.00
|
|
Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
5/1/2012 | published by: Current Partnering
The Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals.
Comprehensive directory of royalty financing deals
|
more...
|
$2,695.00
|
|
Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
5/1/2012 | published by: Current Partnering
The Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare companies.
|
more...
|
$2,695.00
|
|
Research Report on Chinese Bio-pharmaceutical Industry, 2012
3/21/2012 | published by: China Research and Intelligence Co., Ltd.
In China, biological products consist of vaccines, blood products, cytokine, diagnostic reagents and other active agents (including toxins, antigens, allergen, and recombinant DNA products, etc.). In China, animal vaccine belongs to veterinary medicine rather than
|
more...
|
$3,000.00
|
|
Global Biotechnology
4/4/2012 | published by: IBISWorld
Global Biotechnology Biotechnology is the application of science and technology to living organisms as well as parts, products and models thereof, to alter living or non-living materials for the production of knowledge and biotechnology products and
|
more...
|
$935.00
|
|
The US Pharmaceutical Market Outlook to 2016 - Evolving Opportunities in the Biologics Segment
3/1/2012 | published by: AM Mindpower Solutions
EXECUTIVE SUMMARY The report titled “The US Pharmaceutical Market Outlook to 2015 – Evolving Opportunities in the Biologics Segment” provides a comprehensive analysis on the Pharmaceutical market in the US covering various aspects such as market
|
more...
|
$850.00
|
|
Biotechnology in the US - Industry Market Research Report
3/26/2012 | published by: IBISWorld
Biotechnology in the US Wave of the future : Demand for cutting-edge medicines and treatments will result in strong growth for the Biotechnology industry. While it was not entirely immune to the recession, healthcare reform, environmental concerns
|
more...
|
$910.00
|
|
Global Biosimilars Market Forecast to 2015
3/1/2012 | published by: RNCOS
The biosimilars industry has been growing stupendously across the globe for past few years. Increasing healthcare costs and rising aging population are driving the industry, which stands at a vivid position and is expected to
|
more...
|
$1,500.00
|
|
Genencor in Ingredients (World)
3/7/2012 | published by: Euromonitor International
Genencor, which was acquired by DuPont in 2011 and now forms that company’s new Industrial Biosciences division, is one of the largest biotechnology operations in the world. This profile assesses the company’s structure, strategies and
|
more...
|
$520.00
|
Related Markets
- Biotechnology
- Biotechnology Company Reports
- General Biotechnology
- Pharmaceuticals
- Biopharmaceuticals
Biopharmaceuticals Reports
- Research Report on Chinese Bio-pharmaceutical Industry, 2012
- Regulatory Intelligence on Biologics Recalls – Immunoglobulins and Vaccines are Involved in More Recalls than Other Drug Classes
- Biologics Market in Brazil
- Global Biosimilars Market Forecast to 2015
- Biosimilars: Current Situation & Future Prospects, Worldwide
